Drug candidate successfully treats atherosclerosis and fatty liver disease in large mammals

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis—a primary driver of cardiovascular death worldwide—in large mammals, a study suggests.

Leave A Comment

Your email address will not be published. Required fields are marked *